Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Market-index investing offers broad exposure, low fees, and robust diversification, making it a straightforward way to participate in market growth.
28,294 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Medicare is tightening oversight on hospice providers amid rising admissions and fraud concerns. The crackdown could ...
Could Ethereum steal the spotlight from Bitcoin in the next three years? This guide lays out the case, the risks, and...
Stripe's Patrick Collison warns a surge in token theft is upending the AI startup landscape, forcing changes to free ...
President Trump pushes to suspend the federal gas tax to lower pump prices, but analysts say higher oil prices and fu...
With the Social Security trust fund edging toward depletion, retirees and workers wonder what will actually happen ne...
Qualcomm has vaulted from March lows as auto and IoT growth accelerates. Yet market skeptics linger, with hyperscaler...
A high-profile AI-safety case highlights a common truth for investors: safety cannot be left to one person. The artic...
As wage growth continues to vary, a well‑constructed $1 million portfolio can quietly deliver steady cash flow that r...
A cash-rich automotive underdog is drawing value-focused investors as market conditions shift in 2026. Analysts see p...
Li Auto's 2026 earnings outlook hinges on shipments, margins, and smart capital allocation. This deep dive breaks dow...
Netflix and Spotify face off for retirement portfolios as mid-2026 conditions test growth, margins, and free cash flo...